ClinConnect ClinConnect Logo
Search / Trial NCT05297331

Renal Stone Treatment Global Registry

Launched by CHINESE UNIVERSITY OF HONG KONG · Mar 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Urolithiasis Eswl Rirs Flexible Ureteroscopy Pcnl Fans Flexible And Navigable Suction Ureteral Access Sheath Intrarenal Pressure Irp Intrarenal Temperature Irt

ClinConnect Summary

This clinical trial is looking at how well different surgical treatments work for people with urinary stones, also known as urolithiasis. Researchers want to collect information about the outcomes of these treatments and any complications that may occur. The goal is to better understand which approaches are most effective for patients.

To participate in this trial, you need to be at least 18 years old and able to give your consent to join. Both men and women can take part in the study, which is currently recruiting participants. If you decide to join, you can expect to have your treatment and any related health outcomes monitored closely. This information will help doctors improve care for future patients with urinary stones.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient at the age of 18 or above
  • Exclusion Criteria:
  • Patient is unable to give consent

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Shatin, , Hong Kong

Hong Kong, , Hong Kong

Sheung Shui, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Chi Fai NG, MD

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials